Inclusion criteria
liver stiffness, cirrhosis, admissionSubject, ascites
ASCITES, CIRRHOSIS, STERILE, ONCOLOGY, PORTAL HYPERTENSION

Patients with cirrhosis confirmed by histology or liver stiffness or with unequivocal signs in ultrasound, endoscopy, and/or blood testsClinically evident ascites due to portal hypertension (serum-ascites-albumin-gradient (SAAG) > 1.1 g/dL)HRS-AKI stages 2 or 3Planned vasoactive treatment for the management of HRS, as defined by the administration of terlipressin + albuminAge: ≥ 18 to ≤ 75 years old at the time of consentECOG (Eastern Cooperative Oncology Group) score < 4 prior to hospital admissionSubject has been informed of the nature of the study, is willing to comply with all required follow-up evaluations within the defined follow-up visit windows, and has signed an Ethics Committee (EC) approved consent form.Female subjects of childbearing potential have a negative pregnancy test ≤ 7 days before the procedure and are willing to use a reliable method of birth control for the duration of study participation. Female subjects will be exempted from this requirement in case they are sterile, infertile, or have been post-menopausal for at least 12 months (no menses). A contraceptive method with a pearl index below 1% is assumed to be effective.